RT Journal Article
SR Electronic
T1 Is the Sars-CoV-2 virus a possible trigger agent for the development of achalasia?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.09.19.22280068
DO 10.1101/2022.09.19.22280068
A1 Furuzawa-Carballeda, Janette
A1 Icaza-Chávez, María Eugenia
A1 Aguilar-León, Diana
A1 Uribe-Uribe, Norma
A1 del Carmen Nuñez-Pompa, María
A1 Trigos-Díaz, Alonso
A1 Areán-Sanz, Rodrigo
A1 Fernández-Camargo, Dheni A.
A1 Enrique, Coss-Adame E
A1 Valdovinos, Miguel A.
A1 Briceño-Souza, Eduardo
A1 Chi-Cervera, Luis A.
A1 Olivares-Flores, Miriam
A1 Torres-Villalobos, Gonzalo
YR 2022
UL http://medrxiv.org/content/early/2022/09/20/2022.09.19.22280068.abstract
AB BACKGROUND Previous studies have suggested that achalasia is an autoimmune disease whose probable causal agent is a neurotropic virus that chronically infects the myenteric plexus of the esophagus and, in a genetically susceptible host, induces the disease. The association between achalasia and coronaviruses has not been reported in the literature.AIMS To evaluate the presence of the SARS-CoV-2 virus, the ACE2 expression, the tissue architecture, and immune response in the lower esophageal sphincter muscle (LESm) of achalasia patients who had SARS-CoV-2 (achalasia-COVID-19) infection before laparoscopic Heller myotomy (LHM) and compare the findings with type II achalasia patients and transplant donors (controls) without COVID-19.METHODS The LESm of 7 achalasia-COVID-19 patients (diagnosed by PCR), ten achalasia patients, and ten controls without COVID-19 were included. The presence of the virus was evaluated by in situ PCR and immunohistochemistry. ACE2 receptor expression and effector CD4 T cell and regulatory subsets were determined by immunohistochemistry.RESULTS Coronavirus was detected in 6/7 patients-COVID-19. The SARS-CoV-2 was undetectable in the LESm of the achalasia patients and controls. The ACE2 receptor was expressed in all the patients and controls. One patient developed achalasia type II post-COVID-19. The percentage of Th22/Th17/Th1/pDCreg was higher in achalasia and achalasia-COVID-19 pre-HLM vs. controls. The Th2/Treg/Breg cell percentages were higher only in achalasia vs. controls.CONCLUSION The presence of the SARS-CoV2 and its receptor in the LESm of type II achalasia-COVID-19 patients but not in the controls suggests that it could affect the myenteric plexus. Unlike achalasia, patients-COVID-19 have an imbalance between effector CD4 T cells and the regulatory mechanisms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work was performed according to the principles expressed in the Declaration of Helsinki. The ethical committee from the Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran approved the study, and written informed consent was obtained from all subjects (Ref. No. 1522).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.